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1. Introduction 
The different aminoacyl-tRNA synthetases are 
enzymes with a high degree of specificity towards both 
amino acid and tRNA [l] . It is known that aminoacyl- 
tRNA synthetases in mammalian cells are organised in 
complexes in the cell sap [2-51. The mechanism of 
action of the aminoacyl-tRNA synthetases was studied 
thoroughly by several investigators who have reported 
a number of inhibitors of these enzymes [6]. 
Carbobenzoxy, phenylacetyl and phenylpropionyl 
derivatives of amino acids, especially those with more 
than one aromatic group, were found to inhibit 
growth of Ehrlich ascites tumor in mice [7,8]. These 
compounds also inhibit several enzymes from differ- 
ent sources [9-141. It was reported earlier [ 151 that 
some of these acyl derivatives of amino acids inhibit 
the poly U promoted incorporation of phenylalanine 
into 5% hot TCA insoluble material in cell free protein 
synthesizing systems prepared from Ehrlich ascites 
cells and from rat and mouse liver. These inhibitors 
were shown to inhibit the formation of phenylalanyl- 
tRNA but did not inhibit the synthesis of valyl-tRNA 
[ 151. The effect of acyl derivatives of amino acids on 
the different aminoacyl-tRNA synthetases from mouse 
liver and Ehrlich ascites tumor cells is described in this 
communication. 
2. Materials and methods 
14C-labeled amino acids were purchased from 
Radiochemical Centre, Amersham, England. Specific 
activities (mCi/mmole) as follows: Ala 156; Asp 229; 
Asn 218; Glu 28.5; Gly 108; Ile 342; Leu 342; Met 
North-Holland Publishing Company - Amsterdam 
56; Phe 475; Pro 265; Ser 160; Thr 208; Val280. 
t3H] Val, sp.ac. 4000 mCi/mmole was purchased 
from Kamag, Israel. 
N-CBZS-benzyl-Lcysteine and OL, e-di-CBZ-L 
lysine were purchased from Fluka A. G. Buchs, 
Switzerland. CBZ-Lglutamic acid y-benzyl ester was 
prepared according to Hanby et al. [ 161. N-phenyl- 
acetyl and N-phenylpropionyl-s-benzyl-Lcysteine 
were prepared according to Lustig et al. [ 121. All the 
inhibitors were used in the form of their alkali metal 
salts [15]. 
Mouse liver was homogenized 1: 1 (w/v) in TKMS 
buffer containing: 50 mM Tris-HCl (pH 7.4) 25 mM 
KCl, 10 mM MgClz, 0.25 M sucrose. Ehrlich ascites 
cells were crushed with a French press at a pressure 
of 8000 psi. Aminoacyl-tRNA synthetases were prepar- 
ed from post microsomal supematant as described by 
Geels [2]. tRNA from mouse liver and Ehrlich ascites 
cells were prepared according to Bauer et al. [ 171. The 
purity of tRNA isolated from mouse liver and Ehrlich 
ascites cells was checked by microgel electrophoresis 
[ 181.90% of the RNA moved as 4 S material. Protein 
content was measured by the method of Lowry et al. 
[191. 
The reaction mixture contained in final volume of 
0.22 ml the following: 0.1 M Tris-HCl (pH 7.4) 10 
mM MgCls, 2 mM ATP, 20 mM mercaptoethanol, 20 
c(g BSA, 14C-labeled amino acid: 0.2 &i each (5.6- 
50 PM), 100-800 c(g tRNA, synthetases from Ehrlich 
ascites cells: 4.6 c(g protein, synthetases from mouse 
liver: 8.0 c(g protein. All incubations were performed 
at 37°C. In all reaction mixtures the tRNA and the 
enzyme were from one and the same source. The 
reaction was started by adding enzyme preparation, 
0.05-o. 1 ml of sample was withdrawn, washed and 
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counted as ‘5% cold TCA-insoluble material’ as describ- 
ed. Time of the reaction (2-10 min) was chosen in 
the constant velocity range. In all cases the reaction 
rate was linear with the enzyme concentration and 
was not dependent on the substrates’ concentrations. 
3. Results and discussion 
As can be seen from table 1, the activities of the 
crude synthetases preparations both from Ehrlich ascites 
cells and mouse liver vary in respect to different amino 
acids. This may be explained by the different distribu- 
tion of the synthetases in the cell sap or by artifacts 
induced during isolation 1201. The activity of most of 
aminoacyl-tRNA synthetases from Ehrlich ascites cells 
is significantly higher than those from mouse liver. 
This fact can be explained in terms of higher activity 
(or greater stability) of synthetases derived from Ehrlich 
ascites tumor, or by the inherently greater purity of 
Ehrlich ascites enzyme preparation. 
Methionine 182 10 
Aspartic acid 449 40 
Isoleucine 409 - 
Valine 400 120 
Glutamic acid 280 20 
Serine 204 60 
Threonine 196 90 
Glycine 160 - 
Phenylalanine 120 40 
Leucine 102 11 
Asparagine 102 - 
Alanine 36 43 
Proline - 85 
Activities of enzyme: pmole aminoacyl-tRNA synthesized .
mg-’ . min.‘. 
From tables 2 and 3 one can see that different tRNA, Met-tRNA, Asn-tRNA, Ile-tRNA are inhibited 
aminoacyl-tRNA synthetases how different response by 40-60% and Thr-tRNA, Ala-tRNA, Val-tRNA, 
to the same inhibitor. 5 mM N-CBZS-benzyl-Lcysteine Ser-tRNA, Pro-tRNA synthetases are affected much 
strongly (above 60%) inhibits Phe-tRNA, Glu-tRNA less. In general, the synthetases that are most sensitive 
and Gly-tRNA synthetases, while Asp-tRNA, L.eu- to N-CBZ-S-benzyl-Lcysteine are also sensitive to the 
Table 1 
The activity of aminoacyl-tRNA synthetases from mouse 
liver and Ehrlich ascites cells. 
Amino acid E. ascites cells Mouse liver 
Table 2 
The percentage activity of aminoacyl-tRNA synthetases from Ehrlich ascites cells in 
the presence of inhibitors 
Inhibitor 
1 2 3 4 5 
Amino acid 2.5 5.0 1.0 2.5 2.5 2.5 2.5 
mM mM mM mM mM mM mM 
Phenylalanine 
Glutamic acid 
Aspartic acid 
Leucine 
Glycine 
Asparagine 
Isoleucine 
Methionine 
Threonine 
Alanine 
Valine 
Serine 
26 27 22 6 35 60 41 
47 _ - 35 46 74 61 
62 42 - 52 52 - 50 
72 43 - 38 56 78 13 
74 33 81 75 61 78 47 
80 50 85 22 82 81 70 
65 43 89 68 40 85 62 
81 64 - 79 70 110 101 
76 76 81 70 71 71 74 
76 76 93 77 96 77 72 
16 76 - 1-8 93 104 119 
13 13 - 90 97 94 89 
1) N-CBZ-S-benzyl-L-cysteine. 2) OL, e-di-CBZ-L-lysine. 3) CBZ-L-glutamic acid y-benzyl 
ester. 4) N-phenylacetyWbenzyl-L-cysteine. 5) iV-phenylpropionyl-kysteine. 
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Table 3 
The percentage activity of aminoacyl-tRNA synthetases from mouse liver in the 
presence of inhibitors 
Amino acid 
Inhibitor 
1 2 3 4 5 
2.5 5.0 1.0 2.5 2.5 2.5 2.5 
mM mM mM mM mM mM mM 
Phenylalanine 40 19 14 5 39 64 36 
Glutamic acid 41 21 16 42 28 68 69 
Aspartic acid 61 60 90 69 61 86 104 
Leucine 85 53 85 52 89 92 13 
Methionine 79 41 96 89 88 89 103 
Threonine 83 a1 100 97 98 92 91 
Alanine 104 112 106 124 90 98 79 
Valine 95 98 94 91 91 101 101 
Serine 102 90 94 89 88 108 97 
Proline 89 71 110 93 93 116 102 
1) NCBZ-S-benzyl-L-cysteine. 2) or-e-di-CBZ-L-lysine. 3) CBZ-L-glutamic acid y-benzyl 
ester. 4) N-phenylacetylSbenzyl-Lcysteine. 5) N-phenylpropionylSbenzyl-L-cysteine. 
December 1974 
other inhibitors, and synthetases that are unaffected 
or only slightly affected by N-CBZS-benzyl-L-cysteine 
are not inhibited by the other compounds tested. There 
are, however, exceptions: Asn-tRNA synthetase from 
Bhrlich ascites cells is strongly inhibited by Q, e-di- 
CBZ-L-lysine and Gly-tRNA synthetase from the same 
source is almost unaffected by this compound. 
It is known that formation of aminoacyl-tRNA is 
competitively inhibited by structural analogues of 
natural amino acids [6]. There is no structural corre- 
lation between the inhibitor tested and the amino 
acid whose aminoacyl-tRNA synthetase was inhibited. 
Moreover, phenylalanyl-tRNA and glutamyl-tRNA 
synthetases are inhibited to the same extent with N- 
CBZ-S-benzyl-L-cysteine (table 3). 
It is interesting that the same inhibitors that affect 
aminoacyl-tRNA synthetase derived from Ehrlich 
ascites tumor cells inhibit the corr$sponding synthetase 
derived from mouse liver despite the difference in 
activities of these synthetases. 
Since synthetases in mammalian cells exist in com- 
plexes [2-51, it was interesting to see if inhibition of 
the synthesis of an aminoacyl-tRNA has any effect 
on the synthesis of another aminoacyl-tRNA. We, 
therefore, checked inhibition of synthesis of i4C- 
labeled The-tRNA and [3H] Val-tRNA by 2.5 mM 
o, e-di-CBZ-Llysine in the Ehrlich ascites system. As 
shown in table 2, when checked individually, Phe-tRNA 
synthesis is 94% inhibited while Val-tRNA is not affect- 
ed at all. When checked simultaneously, synthesis of 
Table 4 
The activity of Phe-tRNA synthetase from Ehrlich ascites cells after preincubation 
with inhibitor 
System Activity 
cpm/mg prot. 
nondialized synthetase without inhibitor 
nondialized synthetase + a,ediCBZ-L-lysine, 2.5 mM 
nondialized synthetase + dialized a,ediCBZ-L-lysine, 2.5 mM 
dialized synthetase without inhibitor 
synthetase dialized after preincubation for 20 min with a,edi- 
168.10” 
28.10’ 
161 10” 
250. lOa 
CBZ-L-lysme, 2.5 mM 189 . lo3 
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[ 14C] Phe-tRNA is inhibited by 82% and synthesis of 
[3H]Val-tRNA is not inhibited at all. From these data 
it seems likely that, even if the synthetases exist in 
complex in the experimental conditions, they act inde- 
pendently. 
In order to investigate whether the action of the 
inhibitors tested affected the cofactors of the reaction, 
the concentrations of MgCl 2, ATP and mercaptoetha- 
no1 were raised 4-6 fold. In all cases 2.5 mM N-CBZ 
S-benzyl-Lcysteine inhibited the synthesis of Phe- 
tRNA in Ehrlich ascites systems to the same degree. 
Table 4 gives the results of experiments designed 
to test the binding of an inhibitor to synthetase. 
Dialysis by itself did not inactivate the synthetase, 
and the inhibitor easily passed through the dialysis 
membrane. Dialysis of the enzyme after preincubation 
with inhibitor restores enzyme activity to 75% of the 
activity of the enzyme dialysed without preincubation 
with inhibitor, indicating that there is no irreversible 
association between the synthetase and the inhibitor. 
It can be concluded that the synthetase preparation 
from Ehrlich ascites cells, in the conditions described 
above, is more active than the preparation from mouse 
liver; the degree of inhibition of an aminoacyl-tRNA 
synthetase does not depend on the source of the syn- 
thetase; the inhibitors affect some synthetases while 
others are not inhibited; and the inhibition is not 
irreversible. More detailed investigations on the effect 
of acyl derivatives of amino acids on the individual 
amino acyl-tRNA synthetases are being carried out at 
present in our laboratory. 
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